Lam Research Corporation $LRCX Stock Position Trimmed by MASTERINVEST Kapitalanlage GmbH

MASTERINVEST Kapitalanlage GmbH cut its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 38.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 38,334 shares of the semiconductor company’s stock after selling 23,675 shares during the period. MASTERINVEST Kapitalanlage GmbH’s holdings in Lam Research were worth $5,133,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of LRCX. IMG Wealth Management Inc. bought a new position in Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the second quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC bought a new stake in Lam Research during the second quarter worth approximately $29,000. Delos Wealth Advisors LLC acquired a new stake in Lam Research in the second quarter worth approximately $30,000. Finally, REAP Financial Group LLC bought a new position in Lam Research during the 2nd quarter valued at $31,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Price Performance

LRCX opened at $218.36 on Friday. The firm has a market capitalization of $274.27 billion, a P/E ratio of 48.10, a PEG ratio of 2.32 and a beta of 1.77. The stock has a fifty day moving average of $165.99 and a 200-day moving average of $132.80. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $219.59.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the business earned $0.86 EPS. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Insider Activity at Lam Research

In related news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 102,608 shares of company stock valued at $14,916,496. Company insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Rothschild & Co Redburn boosted their price objective on Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. The Goldman Sachs Group restated a “buy” rating and issued a $180.00 price target on shares of Lam Research in a research report on Friday. Jefferies Financial Group reaffirmed a “buy” rating and issued a $200.00 price target (up previously from $175.00) on shares of Lam Research in a report on Monday, December 15th. Morgan Stanley raised their price objective on Lam Research from $137.00 to $158.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 2nd. Finally, HSBC set a $127.00 target price on Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. Twenty-six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $164.37.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.